Who owns CANDEL THERAPEUTICS, INC?
- Ticker: CADL
- CUSIP Number: 137404109
Tip: Access positions for across all investors
Analyze quarterly positions in Candel Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Candel Therapeutics stock
Who bought or sold CANDEL THERAPEUTICS, INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| FMR | 7.1M | $40M | 81% | Mar 2025 |
|
| Baker Bros. Advisors | 2.4M | $14M | -18% | Mar 2025 |
|
| Acorn Capital Advisors | 2.2M | $12M | 11% | Mar 2025 |
|
| BlackRock | 1.8M | $10M | 49% | Mar 2025 |
|
| Vanguard Group | 1.7M | $9.8M | 30% | Mar 2025 |
|
| Portolan Capital Management | 881k | $5.0M | 17% | Mar 2025 |
|
| Halter Ferguson Financial | 777k | $3.9M | 12% | Jun 2025 |
|
| Susquehanna International | 704k | $4.0M | -47% | Mar 2025 |
|
| Geode Capital Management | 688k | $3.9M | 51% | Mar 2025 |
|
| State Street Corporation | 563k | $3.2M | 0% | Mar 2025 |
|
| Citadel Advisors | 328k | $1.9M | -52% | Mar 2025 |
|
| Northern Trust | 236k | $1.3M | 43% | Mar 2025 |
|
| Marshall Wace | 235k | $1.3M | 100% | Mar 2025 |
|
| Franklin Resources | 211k | $1.2M | 100% | Mar 2025 |
|
| Millennium Management | 209k | $1.2M | 560% | Mar 2025 |
|
| UBS Group | 187k | $1.1M | 19% | Mar 2025 |
|
| HB Wealth Management | 94k | $533k | 8% | Mar 2025 |
|
| Jane Street | 90k | $509k | 92% | Mar 2025 |
|
| Charles Schwab Investment Management | 84k | $474k | 61% | Mar 2025 |
|
| Nuveen | 78k | $442k | 100% | Mar 2025 |
|
| Squarepoint Ops | 75k | $424k | 289% | Mar 2025 |
|
| Commonwealth Equity Services | 65k | $368k | 58% | Mar 2025 |
|
| Bank of New York Mellon | 61k | $343k | 35% | Mar 2025 |
|
| Birchview Capital | 60k | $339k | 0% | Mar 2025 |
|
| Goldman Sachs Group | 55k | $309k | -16% | Mar 2025 |
|
| Mml Investors Services | 48k | $274k | -2% | Mar 2025 |
|
| Moneta Group Investment Advisors | 39k | $220k | 100% | Mar 2025 |
|
| Balyasny Asset Management | 38k | $213k | 100% | Mar 2025 |
|
| Rhumbline Advisers | 33k | $188k | 27% | Mar 2025 |
|
| Barclays | 31k | $177k | -9% | Mar 2025 |
|
| Intech Investment Management | 29k | $161k | 100% | Mar 2025 |
|
| Deutsche Bank Aktiengesellschaft | 26k | $148k | -17% | Mar 2025 |
|
| Stratos Wealth Advisors | 23k | $130k | 100% | Mar 2025 |
|
| Raymond James Financial | 23k | $128k | 100% | Mar 2025 |
|
| Janney Montgomery Scott | 21k | $119k | 104% | Mar 2025 |
|
| AQR Capital Management | 21k | $119k | -4% | Mar 2025 |
|
| Citigroup | 20k | $114k | 9% | Mar 2025 |
|
| Axq Capital | 20k | $113k | 100% | Mar 2025 |
|
| EntryPoint Capital | 18k | $101k | 100% | Mar 2025 |
|
| Simplex Trading | 17k | $96k | 274% | Mar 2025 |
|
| Mirae Asset Global Etfs Holdings | 17k | $95k | 38% | Mar 2025 |
|
| MetLife Investment Advisors | 15k | $86k | 11% | Mar 2025 |
|
| Jpmorgan Chase & Co | 14k | $81k | 37% | Mar 2025 |
|
| Corebridge Financial | 14k | $79k | 29% | Mar 2025 |
|
| Advisor Group Holdings | 14k | $78k | 356% | Mar 2025 |
|
| Wells Fargo & Company | 14k | $77k | 34% | Mar 2025 |
|
| Mariner Wealth Advisors | 11k | $64k | 100% | Mar 2025 |
|
| Quest Partners | 11k | $61k | 100% | Mar 2025 |
|
| Creative Planning | 11k | $61k | 100% | Mar 2025 |
|
| Alliancebernstein | 11k | $60k | 0% | Mar 2025 |
|
| Invesco | 10k | $59k | 100% | Mar 2025 |
|
| Private Advisor | 10k | $59k | 100% | Mar 2025 |
|
| Taylor Financial Group | 10k | $57k | 100% | Mar 2025 |
|
| Russell Investments | 4.7k | $27k | 26% | Mar 2025 |
|
| Legal & General Group | 3.1k | $18k | 41% | Mar 2025 |
|
| Federation des caisses Desjardins du Quebec | 3.0k | $17k | 200% | Mar 2025 |
|
| Royal Bank of Canada | 2.7k | $15k | 406% | Mar 2025 |
|
| Tower Research Capital | 2.1k | $12k | 43% | Mar 2025 |
|
| Summit Investment Advisors | 1.9k | $11k | 0% | Mar 2025 |
|
| New York State Common Retirement Fund | 1.7k | $10k | 0% | Mar 2025 |
|
| California State Teachers Retirement System | 1.6k | $9.1k | 0% | Mar 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.4k | $7.7k | -60% | Mar 2025 |
|
| Amalgamated Bank | 980.00 | $6.0k | 43% | Mar 2025 |
|
| Jones Financial Companies, L.L | 456.00 | $2.7k | 100% | Mar 2025 |
|
| Us Bancorp | 416.00 | $2.3k | 100% | Mar 2025 |
|
| CWM | 297.00 | $2.0k | 5840% | Mar 2025 |
|
| Hanson McClain Advisors | 45.00 | $225.000000 | 100% | Mar 2025 |
|
| NISA Investment Advisors | 44.00 | $249.000400 | 91% | Mar 2025 |
|
| Sterling Capital Management | 41.00 | $231.998500 | 105% | Mar 2025 |
|
| Signature | 39.00 | $219.999000 | 100% | Mar 2025 |
|
| EverSource Wealth Advisors | 38.00 | $215.000200 | 100% | Mar 2025 |
|
| GAMMA Investing | 33.00 | $166.999800 | -82% | Jun 2025 |
|
| SBI Securities | 10.00 | $57.000000 | 0% | Mar 2025 |
|
| True Wealth Design | 8.00 | $46.000000 | 100% | Mar 2025 |
|
Who sold out of Candel Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Braidwell | Dec 2024 | 1.6M | $14M |
| Bridgeway Capital Management | Dec 2024 | 77k | $670k |
| Maven Securities | Dec 2024 | 52k | $449k |
| Oppenheimer & Co | Dec 2024 | 38k | $329k |
| Heights Capital Management | Dec 2024 | 30k | $260k |
| Vontobel Holding | Dec 2024 | 19k | $165k |
| Carnick & Kubik | Dec 2024 | 15k | $131k |
| Oxford Asset Management | Dec 2024 | 12k | $104k |
| LPL Financial | Dec 2024 | 11k | $93k |
| UMA Financial Services | Mar 2025 | 76.00 | $430.000400 |